Vasan Yegnasubramani
@Yegnalab
Followers
316
Following
108
Media
0
Statuses
95
Vasan Yegnasubramanian is a cancer researcher at Johns Hopkins University (@HopkinsMedicine).
Baltimore, MD
Joined April 2012
@MindyKimGraham @biorxivpreprint Congrats to @MindyKimGraham, @rvchikar, and Rulin Wang for leading this effort.
0
0
8
As part of the new national Cancer AI Alliance (CAIA), Johns Hopkins oncologists and engineers will develop projects centered on using AI to enable precision cancer care. Read more: https://t.co/x1Qu2ZcVPj
#precisionmedicine #cancer #AI
hopkinsmedicine.org
0
1
1
.@theNCI-designated cancer centers @DanaFarber, Fred Hutch, @MSKCancerCenter and @KimmelCancerCtr have joined forces and secured funding from #AI technology leaders @AWS, @Deloitte, @Microsoft and @nvidia, to create the Cancer AI Alliance (CAIA).
fredhutch.org
3
12
52
I am happy to share that our most recent work on prostate cancer from @Yegnalab (co-first author Rulin Wang) was published today in @NatureComms. This was a real team effort, with many folks to thank for their contribution
nature.com
Nature Communications - Alterations in the tumour microenvironment (TME) can contribute to prostate cancer progression, but it is unclear how tumours mediate those changes. Here, analysis of human...
1
7
14
We are thrilled to introduce our incoming @Hopkins_HemOnc fellowship class - what a brilliant & inspiring group of physicians. Can't wait to have you all here in Baltimore! @hopkinskimmel
@kamarroneMD @redcell_doc @JZimmermanMDPhD @LeukDocWebster @MarkYarchoan #AnaDeJesusAcosta
4
15
111
For much more discussion and detail, please check out our full preprint on medrXiv: https://t.co/R82lnI9iWD This is the result of a huge collaborative effort with @Yegnalab @EugeneSemenovMD @SashaGusevPosts @mkwatra @HannahCornman @AnushaKambala @OladipoSola & many more!! 8/8
0
2
13
Gratified to present the results of the first stage of BR.36 #ctDNA molecular response adaptive #immunotherapy clinical trial at @hopkinskimmel , together with @josephcmurray & @LavanyaSivapal1's soon-to-be-published study on heterogeneity of IO response https://t.co/Xfg4aConqW.
Join us in the @hopkinskimmel series of cutting edge #Technology featuring #liquid biopsies this week. @josephcmurray & myself will be discussing 2 new studies on #liquidbiosies from @HopkinsThoracic coming out soon & bridging scientific discovery with clinical #Cancer care.
0
7
31
Excited to share our preprint from @Yegnalab. We applied scRNA-seq and histomorphology in human prostate cancer and GEMMs to uncover the underlying biology driving convergent neoplastic patterns in carcinogenesis despite tumor heterogeneity.
1
2
11
@Hopkins_MTB is now @theNCI funded! Over the next few years will intensify our efforts to generate automated precision oncology decision-support systems linking genotypes with therapies at @hopkinskimmel & in the community. Thanks to our great clinical-genomic-informatics team!
3
7
35
We are super excited to welcome the Class of 2026 to our program. They are all outstanding individuals who will do really well here @hopkinskimmel. Congratulations! #1Fellowship1Family
4
15
110
We're proud to share the latest research and innovation in urologic care at @HopkinsMedicine - read the latest DISCOVERY issue, a publication of the Patrick C. Walsh Prostate Cancer Research Fund. https://t.co/8MjXXhvRdq
1
7
19
Excited to share this scRNA-seq resource from the @Yegnalab, with several folks contributing to this work, including Rulin Wang, @rvchikar, De Marzo lab, Chuck Bieberich, @SimonsLab, and the SKCCC Experimental and Computational Genomics Core.
onlinelibrary.wiley.com
Background Evaluating the complex interplay of cell types in the tissue microenvironment is critical to understanding the origin and progression of diseases in the prostate and potential opportunit...
1
2
8
Huge thanks to our symposium speakers: @mike_schatz @SmithImmunology @atulpdeshpande @MindyKimGraham @wonjinho1 @ProteomicsNews @nikolausschultz and our faculty organizers @FertigLab @Yegnalab !!
0
1
6
Just saw this article on your new role as Deputy Cancer Center Director at Vanderbilt! @benhopark
https://t.co/W1MqN9tXex
news.vumc.org
Ben Ho Park, MD, PhD, Cornelius Abernathy Professor of Medicine, has been named deputy director of Vanderbilt-Ingram Cancer Center (VICC).
1
0
7
Two castration resistant prostate cancer cell lines with deep molecular/phenotypic characterization to add to the PCa research armamentarium! Congrats @M_Haffner, @bhamidipati97 and team!
0
7
24
Our team of researchers are making moves to intercept cancer before it spreads.
0
6
18
For anyone interested in a post-doc position in an aging/cancer research lab, this would be a fantastic opportunity in the Weeraratna lab @AshaniTW !
Tweeps! Please RT- Announcing post-doctoral fellowships in my laboratory- yes more than one- we are looking to build the lab. Are you interested in the tumor microenvironment? Lipids? Aging of the TME? Fibroblasts and immune cells and what they do during aging and cancer? 1/2
1
1
7
A new consensus on the nomenclature for ADP-ribosyltransfereases, aka PARP. PARP is now a name by itself, not an acronym, to refer this enzyme class. A much-needed initiative led by Prof. Bernhard Lüscher, agreed by leaders in academia and industry https://t.co/auS1LvxYpr
0
8
19
Hey Tweeps!! Spread the word: The Dept of Cell Biology, @HopkinsMedicine led by Andy Ewald, is searching for 1-2 assistant or associate professors in any subfield of cell biology! You can check out the deets and apply at:
1
130
161
A TCR barcoding system reveals how functional programming of immune cells associates with therapy response in lung cancer patients, according to a Nature paper. The findings provide important insights for overcoming resistance to PD-1 blockade. https://t.co/w14bLpn27k
1
9
33